Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2014 / Cilt: 48 - Sayı: 1

Survival after severe metabolic acidosis (pH=6.66)

Ciddi Metabolik Asidoz Sonrası Sağkalım: (pH= 6.66)

Pages
64–66
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Result: It should be considered that risk of severe metabolic acidosis and planing early and suitable therapy when developed diarrhea in patients who are used chemotherapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Backround: Metabolic acidosis is an acid-base disturbance, which is characterized by primary consumption of body buffers and causing decreased blood HCO3- level.
📊
Key Findings & Data:In this article we discus a case with severe metabolic acidosis (pH=6.66) due to diarrhea that was caused by chemotherapeutic agents.
💡
Conclusion & Impact:Result: It should be considered that risk of severe metabolic acidosis and planing early and suitable therapy when developed diarrhea in patients who are used chemotherapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Backround: Metabolic acidosis is an acid-base disturbance, which is characterized by primary consumption of body buffers and causing decreased blood HCO3- level. In this article we discus a case with severe metabolic acidosis (pH=6.66) due to diarrhea that was caused by chemotherapeutic agents. Case: The patient was a male aged 20 and had colon cancer with bone metastase. He started getting chemotherapy three months ago. When he was seen in the emergency service he was unconscious and had convulsion. He had diarrhea in his history. He was intubated and put on the mechanical ventilator after admittance to the ICU. Arteriel blood gas values were pH: 6.66, PaCO2: 102 mmHg, PaO2: 307 mmHg, HCO3: 10.7 mmol L-1, SpO2: %97, BE: -23 mmol L-1 and laktat: 28 mmol L-1. Convulsion were stopped after giving benzodiazepine and barbiturate respectively. Fluid and NaHCO3 replacement were provided. After ten hours arteriel blood gas values were measured as normal and he was extubated. He was transferred to an oncology clinic after observation for 3 days. Result: It should be considered that risk of severe metabolic acidosis and planing early and suitable therapy when developed diarrhea in patients who are used chemotherapy.

Özet

Giriş: Metabolik asidoz, kanda bikarbonat konsantrasyonunda azalmaya neden olan, vücut tamponlarının birincil tüketimi ile karakterize bir asit-baz bozukluğudur. Bu olguda kemoterapötik kullanımına bağlı diyare nedeni ile yaşamla bağdaşmayan derin metabolik asidoz (pH=6.66) gelişen olguyu sunmayı amaçladık. Olgu: Kolon kanseri ve kemik metastazı tanısıyla 3 ay önce kemoterapi başlanmış olan 20 yaşındaki erkek hasta ani bilinç kaybı, konvülsiyon ve diyare nedeniyle acil servise başvurduğunda tarafımızdan değerlendirildi. Entübe edilerek reanimasyon ünitesine alınan hastanın burada alınan arteriyel kan örneğinde pH: 6.66, PaCO2: 102 mmHg, PaO2: 307 mmHg, HCO3: 10,7 mmol L-1, SpO2: %97, BE: -23 mmol L-1, laktat: 28 mmol L-1 olarak saptandı. Mekanik ventilatöre bağlanan hastanın konvülsiyonları sırası ile benzodiazepin ve barbitürat kullanılarak durduruldu. Hastaya sıvı ve sodyum bikarbonat replasmanı yapıldı. Arteriyel kan gazı değerleri 10 saat sonra normal olarak saptanan hasta ekstübe edildi. Yoğun bakım ünitesinde 3 gün takip edildikten sonra dış merkezde onkoloji kliniğine transfer edildi. Sonuç: Malignensi tanısı olan ve kemoterapi uygulanan hastalarda diyare gelişmesi durumunda derin metabolik asidoz gelişebileceği göz önünde tutulmalı, erken ve uygun tedavi planlanmalıdır.

🔖

Cite This Article

SEVDİ, M. S., AYDOĞMUŞ, M. T., ERKALP, K., GÜMÜŞ, F., ALAGÖL, A. (2014). Survival after severe metabolic acidosis (pH=6.66). Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 48 - Sayı: 1, 64–66. https://ajindex.com/articles/363796

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Emmett M. Anion-gap interpretation: the old and the new. Nature Clin Pract Nephrol 2006; 2: 4-5
  2. Lim S. Metabolic Acidosis. Acta Med Indones 2007; 39: 145-50
  3. Sabatini S, Kurtzman NA. Bicarbonate therapy in severe metabolic acidosis. J Am Soc Nephrol 2009; 20: 692-5
  4. Chan JCM, Mak RHK. Acid-base homeostasis. In: Avner ED, Harmon WE, Niaudet P. (eds). Pediatric Nephrology. 5th edition, Philadelphia, Lippincott Williams&Wilkins, 2004, s189-208
  5. Bruno CM, Valenti M. Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review. Hindawi Publishing Corporation Journal of Biomedicine and Biotechnology 2012; Article ID 915150, 8 pages
  6. Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2010; 2: 51-63
  7. Richardson G, Dobish R. Chemotherapy induced diarrhea. J Oncol Pharm Pract 2007; 13: 181-98
  8. Benson AB, Ajani JA, Catalano RB, Engelking C, Kornblau SM, Martenson JA, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 2004; 22: 2918-26
  9. Causso C, Arrieta F, Hernández J, Botella-Carretero JI, Muro M, Puerta C, et al. Severe ketoacidosis secondary to starvation in a frutarian patient. Nutr Hosp 2010; 25: 1049-52
  10. Munoz J, Mohd Khushman, Amr Hanbali, Stoltenberg M. Severe lactic acidosis in a patient with metastatic prostate cancer. J Canser Res Ther 2011; 7: 201-2
  11. Groot R, Sprenger RA, Imholz AL, Gerding MN. Type B lactic acidosis in solid malignancies. Neth J Med 2011; 69: 120-3
  12. Gennari FJ, Weise WJ. Acid-base disturbances in gastrointestinal disease. Clin J Am Soc Nephrol 2008; 3: 1861-68
  13. Keefe DM, Gibson RJ, Hauer-Jensen M. Gastrointestinal mucositis. Semin Oncol Nurs 2004; 20: 38-47
  14. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000; 343: 905-14.